Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5449 Journals

4179 Congresses

9600+ Unique Records

Anticancer Research

Title Abbreviation

Anticancer Res

ISSN

0250-7005

Electronic ISSN

1791-7530

Therapeutic Area

Oncology, Research

Readership

Biomedical Researchers, Clinicians, Oncologists, Physicians, Physicians - Medicine, Researchers, Residents, Scientists

Scope

ANTICANCER RESEARCH is an independent international peer-reviewed journal devoted to the rapid publication of high quality original articles and reviews on all aspects of experimental and clinical oncology. Prompt evaluation of all submitted articles in confidence and rapid publication within 1-2 months of acceptance are guaranteed. Each annual volume contains twelve issues and index. Each issue may be divided into three parts (A: Reviews, B: Experimental studies, and C: Clinical and Epidemiological studies).

Sponsoring Association(s)

International Institute of Anticancer Research (IIAR)

Publisher Name

International Institute of Anticancer Research (IIAR)

To see more details about Anticancer Research, Subscribe Now!

Impact Factor JCR Categories/Rank Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
	– Kait G Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
	– Michael K. Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
	- Weill Cornell Medical Library

Journals ● Congresses ● Associations

Privacy Policy ● Terms of Service ● Glossary ● OSS ● Contact Us